• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[流行病学评估:产前诊断的特殊情况]

[Epidemiological evaluation: the special case of prenatal diagnosis].

作者信息

Aymé S, Julian C

机构信息

INSERM U242, Hôpital d'enfants de la Timone, Marseille.

出版信息

Rev Epidemiol Sante Publique. 1991;39 Suppl 1:S65-73.

PMID:1831279
Abstract

Two procedures of prenatal diagnosis were the subject of epidemiological evaluations. The first one is the screening of Down syndrome among pregnant women 38 years of age and over. The other is the antenatal screening of major malformations by ultrasound. An analysis of the different studies published is presented. The interventions are defined and the frequencies of pathologies involved are given. A review of risks, efficacy and effectiveness of each intervention was then carried out. For Down syndrome screening, the criterion for efficacy and effectiveness is the case prevented. Maximum expected efficacy if the attendance of pregnant women 38 years and over to amniocentesis was 100% is 21%. In practice, the effectiveness (24%) is higher than the efficacy (21%) for the Bouches du Rhône district because health care channels to amniocentesis are not based only on the indication of maternal age. During these last three years in the Bouches du Rhône area, 25% of the trisomies 21 detected were so because amniocentesis was carried out after an abnormal sonographic sign had been detected, and 75% because of maternal age. The limitations of the effectiveness are detailed. For the ultrasound screening of major malformations, the efficacy and the effectiveness are assessed through the intermediate criterion of "number of antenatal diagnoses performed". The overall sensitivity of screening in the general population varied between 55% and 75% according to the studies but it was only between 28% and 39% at the 24th week of gestation. The most often screened anomalies were of the central nervous system and the least often screened were congenital cardiopathies. The two interventions were then compared for their objectives and limitations.

摘要

两项产前诊断程序成为了流行病学评估的对象。第一项是对38岁及以上孕妇进行唐氏综合征筛查。另一项是通过超声进行主要畸形的产前筛查。本文对已发表的不同研究进行了分析。明确了干预措施并给出了所涉及病症的发生率。随后对每项干预措施的风险、疗效和效果进行了综述。对于唐氏综合征筛查,疗效和效果的标准是预防的病例数。如果38岁及以上孕妇进行羊膜穿刺术的参与率为100%,最大预期疗效为21%。在实践中,罗讷河口省的效果(24%)高于疗效(21%),因为通往羊膜穿刺术的医疗保健渠道并非仅基于母亲年龄这一指标。在罗讷河口地区的过去三年里,所检测出的21三体病例中有25%是因为在检测到超声异常征象后进行了羊膜穿刺术,75%是因为母亲年龄。详细阐述了效果的局限性。对于主要畸形的超声筛查,疗效和效果是通过“进行的产前诊断数量”这一中间标准来评估的。根据研究,普通人群筛查的总体敏感性在55%至75%之间,但在妊娠第24周时仅在28%至39%之间。筛查最频繁的异常是中枢神经系统方面的异常,筛查最少的是先天性心脏病。然后对这两项干预措施的目标和局限性进行了比较。

相似文献

1
[Epidemiological evaluation: the special case of prenatal diagnosis].[流行病学评估:产前诊断的特殊情况]
Rev Epidemiol Sante Publique. 1991;39 Suppl 1:S65-73.
2
Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.定期健康检查,1996年更新版:1. 唐氏综合征的产前筛查与诊断。加拿大定期健康检查特别工作组。
CMAJ. 1996 Feb 15;154(4):465-79.
3
Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.孕中期唐氏综合征筛查项目中联合母体血清甲胎蛋白和人绒毛膜促性腺激素的有效性。
Obstet Gynecol. 1994 Aug;84(2):298-303.
4
Fetal Down syndrome screening: a cost effectiveness analysis of alternative screening programs.胎儿唐氏综合征筛查:替代筛查方案的成本效益分析
J Matern Fetal Med. 1999 Nov-Dec;8(6):243-8. doi: 10.1002/(SICI)1520-6661(199911/12)8:6<243::AID-MFM2>3.0.CO;2-N.
5
The antenatal diagnosis of congenital disease.
Otolaryngol Clin North Am. 1981 Feb;14(1):47-57.
6
Prenatal screening for Down syndrome.
Hosp Med. 1998 Aug;59(8):632-6.
7
[Prenatal diagnosis of fetal malformations from the obstetrician's viewpoint].从产科医生角度看胎儿畸形的产前诊断
Wien Klin Wochenschr. 1983 Feb 4;95(3):67-78.
8
A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.一项使用孕妇血清甲胎蛋白、人绒毛膜促性腺激素和未结合雌三醇对孕中期胎儿唐氏综合征进行筛查试验的前瞻性评估。
Obstet Gynecol. 1993 Jan;81(1):72-7.
9
[Gynecological aspects of prenatal diagnosis of congenital anomalies (author's transl)].
MMW Munch Med Wochenschr. 1976 May 7;118(19):589-94.
10
Down syndrome prevention program in a population with an older maternal age.
Obstet Gynecol. 1995 Mar;85(3):368-73. doi: 10.1016/0029-7844(94)00401-X.